Day One Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Day One Stock Summary

Day One competes with Surrozen, Armata Pharmaceuticals, Pasithea Therapeutics, Aditxt, and Scpharmaceuticals. Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California. Day One operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 94 people.

Day One Key Financial Ratios

Day One Key Balance Sheet Accounts

Day One Key Income Statement Accounts

Day One Key Cash Accounts

Day Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Day One's current stock value. Our valuation model uses many indicators to compare Day One value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Day One competition to find correlations between indicators driving Day One's intrinsic value. More Info.Day One Biopharmaceuticals is one of the top stocks in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . At this time, Day One's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Day One's earnings, one of the primary drivers of an investment's value.

Day One Biopharmaceu Systematic Risk

Today, most investors in Day One Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Day One's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Day One growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Day One help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Day One Biopharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Day One Biopharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Day Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Day One's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.